Enterobacteriaceae and Bacteriophages: Implications Against Antimicrobial Resistance

Clicks: 1
ID: 338357
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #82 of 82 articles by views in letters in applied microbiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Enterobacteriaceae represent a clinically challenging bacterial family owing to the global emergence of multidrug resistance. Bacteriophages, the natural predators of these bacteria, have emerged as powerful tools for detecting, targeting, and inhibiting these pathogens. This review provides a comprehensive overview of bacteriophages targeting Enterobacteriaceae hosts, focusing on their diversity, virion architecture, and the molecular determinants of host specificity. The dynamic co-evolution between bacterial defence strategies and phage counter-defences is discussed to illustrate the complexity of the phage-Enterobacteriaceae host interactions. Translational applications of Enterobacteriaceae phages, including phage therapy, engineered phages, phage-derived lysins as antimicrobials, and phage-based diagnostics for rapid and specific pathogen detection is also explored alongside their limitations including limited large-scale clinical trials, regulatory and manufacturing hurdles, and the need for robust host-range prediction and standardization. Overall, this review elaborates implications of bacteriophage-Enterobacteriaceae interactions to combat antimicrobial resistance and support the development of next-generation antibacterial therapies and diagnostics.
Reference Key
openalex_W7225196692 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ramya Ramadoss, Balasubramanian Moovarkumudalvan, Jothimani Pradeep, Divya Lakshmanan
Are you one of these authors? Claim your profile
Journal letters in applied microbiology
Year 2026
DOI
10.1093/lambio/ovag095
URL
https://doi.org/10.1093/lambio/ovag095
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.